Abstract
BackgroundExposure to polychlorinated biphenyls (PCBs) is associated with depressive symptomatology. A cause of depressive symptoms is a disturbance in the neurotransmitter system of dopamine (DA). Animal as well as human studies report that PCBs can influence the DA system. This study examined whether PCB-related depressive symptoms are affected by DA metabolites in humans with high PCB body burden.MethodsThis study is part of the German HELPcB surveillance program (Health Effects in high Level exposure to PCB) for occupationally exposed workers and their relatives. Data was collected from 178 participants on two measurement time points (t1 and t2) with a one-year time lag in between the two time points. PCBs were analyzed in plasma via human biomonitoring and a validated questionnaire was used to identify existence and severity of depressive symptoms. As a surrogate for DA, we measured its metabolites homovanillic acid (HVA) and vanillylmandelic acid (VMA) in urine. Mediation analyses were performed to test whether the association between PCB exposure and severity of depressive symptoms is mediated by urinary concentration of DA metabolites HVA and VMA. The mediation was tested with the SPSS macro MEDIATE.ResultsWe found a significant mediation over time for lower-chlorinated, higher-chlorinated and dioxin-like PCBs. The positive association between PCB exposure with severity of depressive symptoms was mediated by the main DA metabolite HVA. At t1 a higher exposure with PCBs was associated with lower concentration in urinary HVA. A reduced HVA concentration at t1 was correlated with increased depressive symptoms severity at t2. No meditations were found for VMA.ConclusionsThis work indicates that the association of PCB exposure and an increase of depressive symptoms after one year is mediated by the DA metabolite HVA as a surrogate for DA. These are first steps towards finding an explanation for an underlying neurochemical pathomechanism of PCB-related depressive symptomatology.
Highlights
Exposure to polychlorinated biphenyls (PCBs) is associated with depressive symptomatology
We focus on the neurotransmitter system of DA as possible path to explain the association of PCB exposure and depressive symptoms
We examine whether DA level – reflected by urinary metabolite concentration – mediate the positive association of PCB body burden to depressive symptoms in individuals exposed to PCBs through their occupation
Summary
Exposure to polychlorinated biphenyls (PCBs) is associated with depressive symptomatology. This study examined whether PCB-related depressive symptoms are affected by DA metabolites in humans with high PCB body burden. Kilburn et al [7] found higher rates of depressive symptoms in PCB-exposed firefighters compared with a control group, but they found no direct association with PCB body burden. Fitzgerald et al [8] report a strong positive correlation between PCB body burden and depressive symptoms in elderly PCB exposed Hudson River residents. The aim of this study is to explore potential neurophysiological mechanisms that link individual depressive symptoms to PCB exposure. We focus on the neurotransmitter system of DA as possible path to explain the association of PCB exposure and depressive symptoms
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
